Drazner, M. H. 2011. The progression of hypertensive heart disease. Circulation 123:327–334.

Article  PubMed  Google Scholar 

Martin, S. S., A. W. Aday, Z. I. Almarzooq, C. A. M. Anderson, P. Arora, C. L. Avery, C. M. Baker-Smith, B. Barone Gibbs, A. Z. Beaton, and A. K. Boehme et al. 2024. 2024 heart disease and stroke statistics: A report of US and global data from the American heart association. Circulation 149:e347–e913.

Article  PubMed  PubMed Central  Google Scholar 

Mills, K. T., A. Stefanescu, and J. He. 2020. The global epidemiology of hypertension. Nature Reviews Nephrology 16:223–237.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khalid, S. N., T. Mansoor, M. I. Bilal, S. H. Ijaz, M. Fudim, S. J. Greene, V. Nambi, S. S. Virani, G. C. Fonarow, and D. Abramov et al. 2024. Ongoing and future clinical trials of device therapies for patients with heart failure. Current Problems in Cardiology 49:102805.

Article  PubMed  Google Scholar 

Ketabi, M., Z. Mohammadi, Z. Fereidouni, O. Keshavarzian, Z. Karimimoghadam, F. Sarvi, R. Tabrizi, and M. Khodadost. 2024. The effect of recurrent heart failure hospitalizations on the risk of cardiovascular and all-Cause mortality: A systematic review and Meta-Analysis. Current Cardiology Reports 26:1113–1122.

Article  PubMed  Google Scholar 

Khan, M.S., I. Shahid, A. Bennis, A. Rakisheva, M. Metra, and J. Butler. 2024. Global epidemiology of heart failure. Nature Reviews Cardiology 21: 717–734.

Article  PubMed  Google Scholar 

Dordevic, D. B., G. P. Koracevic, A. D. Dordevic, and D. B. Lovic. 2024. Hypertension and left ventricular hypertrophy. Journal of Hypertension 42:1505–1515.

Article  CAS  PubMed  Google Scholar 

Nishida, M., X. Mi, Y. Ishii, Y. Kato, and A. Nishimura. 2024. Cardiac remodeling: Novel pathophysiological mechanisms and therapeutic strategies. J Biochem 176:255–262.

Article  CAS  PubMed  Google Scholar 

Del Re, D. P., D. Amgalan, A. Linkermann, Q. Liu, and R. N. Kitsis. 2019. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiological Reviews 99:1765–1817.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martens, M. D., J. Karch, and J. W. Gordon. 2022. The molecular mosaic of regulated cell death in the cardiovascular system. Biochim Biophys Acta Mol Basis Dis 1868:166297.

Article  CAS  PubMed  Google Scholar 

Ahola, S., and T. Langer. 2024. Ferroptosis in mitochondrial cardiomyopathy. Trends in Cell Biology 34:150–160.

Article  CAS  PubMed  Google Scholar 

Song, Z., J. Wang, and L. Zhang. 2024. Ferroptosis: A new mechanism in diabetic cardiomyopathy. International Journal of Medical Sciences 21:612–622.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun, H., D. Chen, W. Xin, L. Ren, Q. Li, and X. Han. 2023. Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy. Frontiers in Pharmacology 14:1146651.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang, X., B. R. Stockwell, and M. Conrad. 2021. Ferroptosis: Mechanisms, biology and role in disease. Nature Reviews Molecular Cell Biology 22:266–282.

Article  PubMed  PubMed Central  Google Scholar 

Lv, Y., M. Wu, Z. Wang, and J. Wang. 2023. Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases. Cell Biology and Toxicology 39:827–851.

Article  PubMed  Google Scholar 

Ding, K., C. Liu, L. Li, M. Yang, N. Jiang, S. Luo, and L. Sun. 2023. Acyl-CoA synthase ACSL4: An essential target in ferroptosis And fatty acid metabolism. Chin Med J (Engl) 136:2521–2537.

Article  CAS  PubMed  Google Scholar 

Jia, B., J. Li, Y. Song, and C. Luo. 2023. ACSL4-Mediated ferroptosis and its potential role in central nervous system diseases and injuries. International Journal of Molecular Sciences 24:10021.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, B., K. Cheng, T. Wang, X. Peng, P. Xu, G. Liu, D. Xue, N. Jiao, and C. Wang. 2024. Research progress on GPX4 targeted compounds. European Journal of Medicinal Chemistry 274:116548.

Article  CAS  PubMed  Google Scholar 

Wei, C. 2024. The role of glutathione peroxidase 4 in neuronal ferroptosis and its therapeutic potential in ischemic and hemorrhagic stroke. Brain Research Bulletin 217:111065.

Article  CAS  PubMed  Google Scholar 

Yang, X., N. K. Kawasaki, J. Min, T. Matsui, and F. Wang. 2022. Ferroptosis in heart failure. Journal of Molecular and Cellular Cardiology 173:141–153.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, K., X. M. Tian, W. Li, and L. Y. Hao. 2023. Ferroptosis in cardiac hypertrophy and heart failure. Biomedicine & Pharmacotherapy 168:115765.

Article  CAS  Google Scholar 

Bi, X., X. Wu, J. Chen, X. Li, Y. Lin, Y. Yu, X. Fang, X. Cheng, Z. Cai, and T. Jin et al. 2024. Characterization of ferroptosis-triggered pyroptotic signaling in heart failure. Signal Transduct Target Ther 9:257.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fenton, N. M., L. Qian, E. G. Paine, L. J. Sharpe, and A. J. Brown. 2024. A paredox in the control of cholesterol biosynthesis: Does the NADPH sensor and E3 ubiquitin ligase MARCHF6 protect mammalian cells during oxidative stress by controlling sterol biosynthesis? Bioessays 46:e2400073.

Article  PubMed  Google Scholar 

Park, S. E., J. M. Kim, O. H. Seok, H. Cho, B. Wadas, S. Y. Kim, A. Varshavsky, and C. S. Hwang. 2015. Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathway. Science 347:1249–1252.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu, K., S. Itskanov, D. L. Lynch, Y. Chen, A. Turner, J. C. Gumbart, and E. Park. 2024. Substrate recognition mechanism of the Endoplasmic reticulum-associated ubiquitin ligase Doa10. Nature Communications 15:2182.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fenton, N. M., L. Qian, N. A. Scott, E. G. Paine, L. J. Sharpe, and A. J. Brown. 2024. SC5D is the sixth enzyme in cholesterol biosynthesis targeted by the E3 ubiquitin ligase MARCHF6. Biochim Biophys Acta Mol Cell Biol Lipids 1869:159482.

Article  CAS  PubMed  Google Scholar 

Qian, L., N. A. Scott, I. M. Capell-Hattam, E. A. Draper, N. M. Fenton, W. Luu, L. J. Sharpe, and A. J. Brown. 2023. Cholesterol synthesis enzyme SC4MOL is fine-tuned by sterols and targeted for degradation by the E3 ligase MARCHF6. Journal of Lipid Research 64:100362.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scott, N. A., L. J. Sharpe, and A. J. Brown. 2021. The E3 ubiquitin ligase MARCHF6 as a metabolic integrator in cholesterol synthesis and beyond. Biochim Biophys Acta Mol Cell Biol Lipids 1866:158837.

Article  CAS  PubMed  Google Scholar 

Zelcer, N., L. J. Sharpe, A. Loregger, I. Kristiana, E. C. Cook, L. Phan, J. Stevenson, and A. J. Brown. 2014. The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathway. Molecular and Cellular Biology 34:1262–1270.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen, K. T., S. H. Mun, J. Yang, J. Lee, O. H. Seok, E. Kim, D. Kim, S. Y. An, D. Y. Seo, and J. Y. Suh et al. 2022. The MARCHF6 E3 ubiquitin ligase acts as an NADPH sensor for the regulation of ferroptosis. Nature Cell Biology 24:1239–1251.

Article  CAS